TOPAbout TaihoFinancial Highlights

Financial Highlights

Taiho Pharmaceutical Co., Ltd. Fiscal years 2011,2010,2009,2008 and 2007

Millions of yenThousands of U.S. dollars(Note)
Years ended2011 2010 2009 2008 2007 2011
Mar.31,2012 Mar. 31, 2011 Mar. 31, 2010 Mar. 31, 2009 Mar. 31, 2008 Mar. 31, 2012
For the Year:
Net sales¥124,312 ¥123,581 ¥120,716 ¥91,027 ¥128,478 $1,516,000
Operating income16,328 15,778 14,564 11,589 23,072 199,130
Net income10,209 12,127 10,464 8,067 15,183 124,500
Research and development expenses28,094 30,262 29,735 22,439 27,911 342,619
Percentage of net sales(%)22.6% 24.5% 24.6% 24.7% 21.7% 22.6%
Capital expenditures3,927 5,840 4,396 1,469 4,133 47,890
At Year-End:
Total assets¥359,792 ¥354,882 ¥346,619 ¥334,290 ¥331,054 $4,387,713
Total shareholders'equity324,005 319,333 313,019 306,271 299,895 3,951,285
Employees2,557 2,622 2,643 2,513 2,589 2,557

Note : U.S. dollar amounts are translated from yen, for convenience only, at the rate of ¥82=US$1, the approximate exchange rate at March 31,2012.


Top of Page